272 related articles for article (PubMed ID: 24342806)
41. Enhanced bladder capacity and reduced prostaglandin E2-mediated bladder hyperactivity in EP3 receptor knockout mice.
McCafferty GP; Misajet BA; Laping NJ; Edwards RM; Thorneloe KS
Am J Physiol Renal Physiol; 2008 Aug; 295(2):F507-14. PubMed ID: 18508878
[TBL] [Abstract][Full Text] [Related]
42. The phosphatidylinositol 3-kinase inhibitor wortmannin blocks mast cell exocytosis but not IL-6 production.
Marquardt DL; Alongi JL; Walker LL
J Immunol; 1996 Mar; 156(5):1942-5. PubMed ID: 8596048
[TBL] [Abstract][Full Text] [Related]
43. Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells.
Nakayama T; Mutsuga N; Yao L; Tosato G
J Leukoc Biol; 2006 Jan; 79(1):95-104. PubMed ID: 16275896
[TBL] [Abstract][Full Text] [Related]
44. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors.
Singh LK; Boucher W; Pang X; Letourneau R; Seretakis D; Green M; Theoharides TC
J Pharmacol Exp Ther; 1999 Mar; 288(3):1349-56. PubMed ID: 10027877
[TBL] [Abstract][Full Text] [Related]
45. Release of histamine and arachidonate from mouse mast cells induced by glycosylation-enhancing factor and bradykinin.
Ishizaka T; Iwata M; Ishizaka K
J Immunol; 1985 Mar; 134(3):1880-7. PubMed ID: 2578523
[TBL] [Abstract][Full Text] [Related]
46. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
[TBL] [Abstract][Full Text] [Related]
47. Atrial natriuretic peptide induces rat peritoneal mast cell activation by cGMP-independent and calcium uptake-dependent mechanism.
Chai OH; Lee YH; Han EH; Kim HT; Lee MS; Song CH
Exp Mol Med; 2000 Dec; 32(4):179-86. PubMed ID: 11190267
[TBL] [Abstract][Full Text] [Related]
48. Marine brevetoxin induces IgE-independent mast cell activation.
Hilderbrand SC; Murrell RN; Gibson JE; Brown JM
Arch Toxicol; 2011 Feb; 85(2):135-41. PubMed ID: 20549194
[TBL] [Abstract][Full Text] [Related]
49. Crucial involvement of the EP4 subtype of prostaglandin E receptor in osteoclast formation by proinflammatory cytokines and lipopolysaccharide.
Sakuma Y; Tanaka K; Suda M; Yasoda A; Natsui K; Tanaka I; Ushikubi F; Narumiya S; Segi E; Sugimoto Y; Ichikawa A; Nakao K
J Bone Miner Res; 2000 Feb; 15(2):218-27. PubMed ID: 10703923
[TBL] [Abstract][Full Text] [Related]
50. Perfluorooctanoic acid induces mast cell-mediated allergic inflammation by the release of histamine and inflammatory mediators.
Singh TS; Lee S; Kim HH; Choi JK; Kim SH
Toxicol Lett; 2012 Apr; 210(1):64-70. PubMed ID: 22322153
[TBL] [Abstract][Full Text] [Related]
51. EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells.
Zeng L; An S; Goetzl EJ
J Pharmacol Exp Ther; 1998 Sep; 286(3):1420-6. PubMed ID: 9732406
[TBL] [Abstract][Full Text] [Related]
52. Effects of PGE2 EP3/EP4 receptors on bladder dysfunction in mice with experimental autoimmune encephalomyelitis.
Xue R; Jia Z; Kong X; Pi G; Ma S; Yang J
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1656-62. PubMed ID: 24154697
[TBL] [Abstract][Full Text] [Related]
53. Comparative evaluation of arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation.
Rao TS; Currie JL; Shaffer AF; Isakson PC
Inflammation; 1993 Dec; 17(6):723-41. PubMed ID: 8112831
[TBL] [Abstract][Full Text] [Related]
54. Mouse prostaglandin E receptor EP3 subtype mediates calcium signals via Gi in cDNA-transfected Chinese hamster ovary cells.
Irie A; Segi E; Sugimoto Y; Ichikawa A; Negishi M
Biochem Biophys Res Commun; 1994 Oct; 204(1):303-9. PubMed ID: 7945376
[TBL] [Abstract][Full Text] [Related]
55. The prostaglandin E2 receptor EP3 controls CC-chemokine ligand 2-mediated neuropathic pain induced by mechanical nerve damage.
Treutlein EM; Kern K; Weigert A; Tarighi N; Schuh CD; Nüsing RM; Schreiber Y; Ferreirós N; Brüne B; Geisslinger G; Pierre S; Scholich K
J Biol Chem; 2018 Jun; 293(25):9685-9695. PubMed ID: 29752406
[TBL] [Abstract][Full Text] [Related]
56. Prostaglandin E
Liu B; Wu X; Zeng R; Yin Y; Guo T; Xu Y; Zhang Y; Leng J; Ge J; Yu G; Guo J; Zhou Y
FASEB J; 2020 Feb; 34(2):2568-2578. PubMed ID: 31908041
[TBL] [Abstract][Full Text] [Related]
57. Mitochondrial uncoupling protein 2 inhibits mast cell activation and reduces histamine content.
Tagen M; Elorza A; Kempuraj D; Boucher W; Kepley CL; Shirihai OS; Theoharides TC
J Immunol; 2009 Nov; 183(10):6313-9. PubMed ID: 19846869
[TBL] [Abstract][Full Text] [Related]
58. Fever During Localized Inflammation in Mice Is Elicited by a Humoral Pathway and Depends on Brain Endothelial Interleukin-1 and Interleukin-6 Signaling and Central EP
Eskilsson A; Shionoya K; Engblom D; Blomqvist A
J Neurosci; 2021 Jun; 41(24):5206-5218. PubMed ID: 33941650
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E2-EP3 signaling.
Li P; Zhao Y; Ge L
Stem Cell Res Ther; 2016 Aug; 7(1):103. PubMed ID: 27484807
[TBL] [Abstract][Full Text] [Related]
60. Blocking the EP3 receptor for PGE2 with DG-041 decreases thrombosis without impairing haemostatic competence.
Tilly P; Charles AL; Ludwig S; Slimani F; Gross S; Meilhac O; Geny B; Stefansson K; Gurney ME; Fabre JE
Cardiovasc Res; 2014 Mar; 101(3):482-91. PubMed ID: 24323317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
